SANUWAVE Health, Inc.(SNWV)— Stock Profile, AI Score & Financials

Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated 2026-06-30.

SANUWAVE Health, Inc. (SNWV) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores SNWV at 63.0/100 on a 32-signal composite quality model, placing it at rank #669 of 2,960 stocks — the top 25% of the AI-ranked universe. SNWV scores in the top quartile across balance sheet strength (99.2), profitability (95.2), revenue growth (91.4). Areas of concern include institutional flow (4.1) and revenue scale (7.8), which score below median versus the broader universe. Shareholder dilution risk is elevated at 15.2/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), SANUWAVE Health, Inc. reports quarterly revenue of $9.7M, net income of $-682.0K, free cash flow of $91.0K. Top institutional holders of SNWV by reported 13-F value include Solas Capital Management, AWM Investment Company, Praetorian PR, based on the most recent SEC filings. SNWV trades on the Nasdaq exchange and files with the SEC under CIK 1417663. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate SNWV daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for SANUWAVE Health, Inc. directly from SEC EDGAR.